Targeted therapy shows benefit for people with advanced breast cancer in late-stage trial | CNN
CNN — An experimental treatment shows promise for people with the most common form of advanced-stage breast cancer, according to the results of a phase 3 clinical trial. the the details of the trial were presented Thursday at the San Antonio Breast Cancer Symposium. He showed that AstraZeneca’s capivasertib, in combination with Faslodex (fulvestrant), an … Read more